You are here

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Checkpoint Blockade Therapy
519 OR641 is a novel dual antagonist antibody that targets LILRB1 and LILRB2 inhibitory receptors and promotes a Th1-like immune response

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023236030
Dec 202357012
Jan 20242003
Feb 20245402
Mar 20246004
Apr 202470010
May 20244000
Jun 20244401
Jul 20245202
Aug 20243003
Sep 20245402
Oct 20245607
Nov 20249204
Dec 20242408
Jan 20254605
Feb 20252603
Mar 2025005
Apr 20250016
May 2025004
Jun 2025002
Total9610123